Immunochemical fecal occult blood test (FOBT) and determination of tumor pyruvate kinase isoenzyme type M2 (TuM2-PK) in stool samples may be valuable new screening tools for colorectal cancer (CRC). The aim of this study was to compare the accuracy of fecal TuM2-PK testing with immunochemical FOBT in patients with CRC or adenomas.
Department of Gastroenterology, Ikazia Ziekenhuis, Montessoriweg 1, Erasmus Medical Center, Dr Molewaterplein 40, Rotterdam, The Netherlands. S.mulder.1@erasmusmc.nl